The present study investigated the molecular mechanism by which ALKBH5‐mediated m6A modification regulates LPS‐induced EMT in SA‐AKI and AKI‐CKD, thus providing a theoretical basis for the management of SA‐AKI. Here, ALKBH5 is linked to chronic kidney disease.